Linkage to Medical Services in the Drug Abuse Treatment Outcome Study

Medical Care

Volumn 39, Issue 3, 2001, Pages 284-295

  Friedmann, Peter D ^a,d   Lemon, Stephenie C ^a   Stein, Michael D ^a   Etheridge, Rose M ^b   D'Aunno, Thomas A ^c  

^a BROWN UNIVERSITY   (United States)

^b SYNEOS HEALTH   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

Case management; Delivery of health care; Drug abuse treatment units; Health services needs and demands; Substance dependence; Transportation

Indexed keywords

ADDICTION; ARTICLE; DRUG DEPENDENCE TREATMENT; EVALUATION; FOLLOW UP; HEALTH CARE DELIVERY; HUMAN; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT REFERRAL; PATIENT SATISFACTION; PROSPECTIVE STUDY; PUBLIC RELATIONS; QUESTIONNAIRE; STATISTICAL MODEL; TRAFFIC AND TRANSPORT; UNITED STATES;

EPISODE OF CARE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERINSTITUTIONAL RELATIONS; LINEAR MODELS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; REFERRAL AND CONSULTATION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TRANSPORTATION; UNITED STATES;

EID: 0035293726     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200103000-00008     Document Type: Article

References (60)

1. Gerstein DR, Datta AR, Ingels JS, et al. NTIES. National Treatment Improvement Evaluation Study: Final report. Rockville, Md: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration; 1997.
2. Anglin MD, Hser YI, Grella CE. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997;11:308-323.
3. O'Brien CP, McLellan AT. Myths about the treatment of addiction. Lancet 1996;347:237-240.
4. Hubbard RL, Marsden ME, Rachal JV, et al. Drug abuse treatment: a national study of effectiveness. Chapel Hill, NC: University of North Carolina Press; 1989.
5. Simpson DD, Sells SB. Effectiveness of treatment for drug abuse: An overview of the DARP research program. Adv Alcohol Subst Abuse 1982;2:7-29.
6. Friedmann PD, Saitz R, Samet JH. Management of adults recovering from alcohol or other drug problems: Relapse prevension in primary care. JAMA 1998;279:1227-1231.
7. McLellan AT, Weisner C. Achieving the public health and safety potential of substance abuse treatment: Implications for patient referral, treatment "matching," and outcome evaluation. In: Bickel WK, DeGrandpre RJ, ed. Drug policy and human nature: Psychological perspectives on the prevention, management, and treatment of illicit drug abuse. New York, NY: Plenum Press; 1996:127-154.
8. Leshner AI. Science-based views of drug addiction and its treatment. JAMA 1999;282:1314-1316.
9. Leukefeld CG, Pickens RW, Schuster CR. Recommendations for improving drug treatment. Int J Addict 1992;27:1223-1239.
10. McLellan AT, Arndt IO, Metzger DS, et al. The effects of psychosocial services in substance abuse treatment. JAMA 1993;269:1953-1959.
11. McLellan AT, Grissom GR, Brill P, et al. Private substance abuse treatments: Are some programs more effective than others? J Subst Abuse Treat 1993;10:243-254.
12. McLellan AT, Hagan TA, Levine M, et al. Supplemental social services improve outcomes in public addiction treatment. Addiction 1998;93:1489-1499.
13. Friedmann PD, Alexander JA, D'Aunno TA. Organizational correlates of access to primary care and mental health services in drug abuse treatment units. J Subst Abuse Treat 1999;16:71-80.
14. Widman M, Platt JJ, Lidz V, et al. Patterns of service use and treatment involvement of methadone maintenance patients. J Subst Abuse Treat 1997;14:29-35.
15. Samet JH, Friedmann PD, Saitz R. Benefits of primary medical care and substance abuse services: Patient, provider and societal perspectives. Arch Intern Med 2001;161:85-91.
16. Stein MD, Samet JH, O'Connor PG. The linkage of primary care services with substance abuse treatment: new opportunities for academic generalists. J Gen Intern Med 1993;8:106-107.
17. Flynn PM, Craddock SG, Hubbard RL, et al. Methodological overview and research design for the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997;11:230-243.
18. Andersen R. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav 1995;36:1-10.
19. Selwyn PA. Overcoming the mind/body dichotomy in drug abuse treatment. Addiction 1996;91:11-13.
20. Selwyn PA, Budner NW, Wasserman WC, et al. Utilization of on-site primary care services by HIV-seropositive and -seronegative drug users in a methadone maintenance program. Public Health Rep 1993;108:492-500.
21. O'Connor PG, Molde S, Henry S, et al. Human immunodeficiency virus infection in intravenous drug users: A model for primary care. Am J Med 1992;93:382-386.
22. Friedmann PD, Alexander JA, Jin L, et al. Medical and psychosocial services in outpatient drug abuse treatment: Do stronger linkages promote client utilization? Health Serv Res 2000;35:443-465.
23. Umbricht-Schneiter A, Gin DH, Pabst KM, et al. Providing medical care to methadone clinic patients: Referral vs on-site care. Am J Public Health 1994;84:207-210.
24. Samet JH, Saitz R, Larson MJ. A case for enhanced linkage of substance abusers to primary medical care. Subst Abuse 1996;17:181-199.
25. D'Aunno TA. Linking substance abuse treatment and primary health care. In: Egertson JA, Fox DM, Leshner AI, eds. Treating drug abusers effectively. Maiden, Mass: Blackwell Publishers; 1997:311-351.
26. Kaluzny AD, Zuckerman HS, Rabiner DJ. Interorganizational factors affecting the delivery of primary care to older Americans. Health Serv Res 1998;33:381-401.
27. Teitelbaum M, Walker A, Gabay M, et al. Analysis of barriers to the delivery of integrated primary care services and substance abuse treatment: Case studies of nine linkage program projects. Rockville, Md, Health Resources and Services Administration and ABT Associates; 1992.
28. Brindis CD, Pfeffer R, Wolfe A. A case management program for chemically dependent clients with multiple needs. J Case Manage 1995;4:22-28.
29. Ridgely MS, Willenbring ML. Application of case management to drug abuse treatment: overview of models and research issues. NIDA Res Monog 1992;127:12-33. DHHS publication (ADM) 92-1946.
30. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9:199-213.
31. Simpson DD, Joe GW. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993; 30:357-368.
32. Littell RC, Milliken GA, Stroup W, et al. SAS system for mixed models. Cary, NC: SAS Institute, Inc; 1996.
33. Sullivan LM, Dukes KA, Losina E. Tutorial in biostatistics: An introduction to hierarchical linear modelling. Stat Med 1997;18:855-888.
34. Etheridge RM, Hubbard RL, Anderson J, et al. Treatment structure and program services in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997;11:244-260.
35. Cohen J, Cohen P. Applied multiple regression/correlation: An analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1975.
36. McLellan AT, Grissom G, Zanis D, et al. Problem-service "matching" in addiction treatment: A prospective study in 4 programs. Arch Gen Psychiatry 1997;54:730-735.
37. Durkin E. The effect of managed care on outpatient substance abuse treatment: An organizational analysis. Chicago, Ill: School of Social Service Administration, University of Chicago; 2000. Dissertation.
38. Kersbergen AL. Case management: a rich history of coordinating care to control costs. Nurs Outlook 1996;44:169-172.
39. Blank AE, Caloir S, Rosado TI, et al. Linking substance abuse patients with a primary care provider: Implications for managed care. Presented at the Association for Health Services Research 13th Annual Meeting, Atlanta, Ga, June 9-11, 1996.
40. McLellan AT, Hagan TA, Levine M, et al. Does clinical case management improve outpatient addiction treatment? Drug Alcohol Depend 1999;55:91-103.
41. Shwartz M, Baker G, Mulvey KP, et al. Improving publicly funded substance abuse treatment: the value of case management. Am J Public Health 1997;87:1659-1664.
42. Siegal HA, Fisher JH, Rapp RC, et al. Enhancing substance abuse treatment with case management: its impact on employment. J Subst Abuse Treat 1996;13:93-98.
43. Shwartz M, Gastfriend DR, Mulvey KP, et al. The Boston Target Cities Program: Overview and evaluation results. J Psychoactive Drugs 1999;31:265-272.
44. Musey VC, Lee JK, Crawford R, et al. Diabetes in urban African-Americans: Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care 1995;18:483-489.
45. Marcus AC, Crane LA, Kaplan CP, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: Results from a large clinic-based trial of three intervention strategies. Med Care 1992;30:216-230.
46. Guidry JJ, Aday LA, Zhang D, et al. Transportation as a barrier to cancer treatment. Cancer Pract 1997;5:361-366.
47. De Leon G, Ziegenfuss JT Jr. Therapeutic communities for addictions. Springfield, Ill: Charles C Thomas; 1986.
48. Institute of Medicine. Federal regulation of methadone treatment. Washington, DC: National Academy Press; 1995.
49. Ayanian JZ. Race, class, and the quality of medical care. JAMA 1994;271:1207-1208.
50. D'Aunno TA, Vaughn TE. An organizational analysis of service patterns in outpatient drug abuse treatment units. J Subst Abuse 1995;7:27-42.
51. Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health 1991;81:1185-1190.
52. Lillie-Blanton M, Parsons PE, Gayle H, et al. Racial differences in health: Not just black and white, but shades of gray. Ann Rev Public Health 1996;17:411-448.
53. Iezzoni LI, Daley J, Shwartz M, et al. Risk adjustment for measuring health care outcomes. Ann Arbor, Mich: Health Administration Press; 1994.
54. Joe GW, Simpson DD, Hubbard RL. Treatment predictors of tenure in methadone maintenance. J Subst Abuse 1991;3:73-84.
55. McCaughrin WC, Price RH. Effective outpatient drug treatment organizations: Program features and selection effects. Int J Addict 1992;27:1335-1358.
56. Hubbard RL, Marsden ME, Allison M. Reliability and validity of TOPS data. Research Triangle Park, NC: Research Triangle Institute; 1984.
57. Simpson DD, Lloyd MR, Gent MJ. Reliability and validity of data: National follow-up study of admissions to drug abuse treatments in the DARP during 1969-1972. Fort Worth, Tex: Texas Christian University, Institute of Behavioral Research; 1976. IBR report 76-18.
58. Zanis D, McLellan AT, Belding MA, et al. A comparison of three methods of measuring the type and quantity of services provided during substance abuse treatment. Drug Alcohol Depend 1997;49:25-32.
59. Weissman JS, Levin K, Chasan-Taber S, et al. The validity of self-reported health-care utilization by AIDS patients. AIDS 1996;10:775-783.
60. Brown JB, Adams ME. Patients as reliable reporters of medical care process: Recall of ambulatory encounter events. Med Care 1992;30:400-411.